Education
About Us
Working with TipRanks
Follow Us
Mark J. Rosenblum Insider Profile
11 Followers
Mark J. Rosenblum, CFO at Advaxis, holds 20.18K shares in Salarius Pharmaceuticals (Ticker: SLRX), holds 113.77K shares in Advaxis (Ticker: ADXS). Most recently, Mark J. Rosenblum Bought ― shares of Salarius Pharmaceuticals on Nov 20, 2025 for an estimated value of $16.00K.
Profitable Transactions
2 out of 5 Profitable Transactions
Average Return
+32.00%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Mark J. Rosenblum holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Feb 13, 2020 - Feb 13, 2021
Return:+192.10%
The most profitable trade made by Mark J. Rosenblum
Mark J. Rosenblum's Trading History
Advaxis
Feb 04, 2014
CFO
Uninformative Buy
―
$9.56K
Salarius Pharmaceuticals
Nov 20, 2025
Exec VP Finance, CFO
Informative Buy
16.00K
$17.55K
List of latest transactions for each holding click on a transaction to see Mark J. Rosenblum's performance on stock
You May Also Like
Mark J. Rosenblum insider profile FAQ
What is the percentage of profitable transactions made by Mark J. Rosenblum?
The percentage of profitable transactions made by Mark J. Rosenblum is 40%.
What is the average return per transaction made by Mark J. Rosenblum?
The average return per transaction made by Mark J. Rosenblum is 32.00%.
What stocks does Mark J. Rosenblum hold?
Mark J. Rosenblum holds: ADXS, SLRX stocks.
What was Mark J. Rosenblum’s latest transaction?
Mark J. Rosenblum latest transaction was an Informative Buy of $16.00K.
What was Mark J. Rosenblum's most profitable transaction?
Mark J. Rosenblum’s most profitable transaction was an Informative Buy of SLRX stock on February 13, 2020. The return on the trade was 192.10%.
What is Mark J. Rosenblum's role in Advaxis?
Mark J. Rosenblum's role in Advaxis is CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.